RG
LOGC

Redmile Group’s LogicBio Therapeutics, Inc. Common Stock LOGC Stock Holding History

Redmile Group’s Portfolio LOGC Stock Details LOGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-749,026
Closed -$8.1M – 81
2019
Q3 		$8.1M Sell
749,026
-65,872
-8% -$705K 0.27% 56
2019
Q2 		$10.6M Sell
814,898
-94,889
-10% -$1.26M 0.3% 56
2019
Q1 		$8.99M Sell
909,787
-1,500
-0.2% -$14K 0.26% 57
2018
Q4 		$9.48M Buy
+911,287
New +$11M 0.38% 51

Other funds holding LOGC

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SC
Samlyn Capital New York $5.82B AUM 36.3% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Sio Capital Management New York $694M AUM 79.73% 1-Year Est. Return